clinical trial · NCT04106908
Effectiveness and Tolerability of Eqwilate in Real-life Conditions
Octapharma·—·active not recruiting·n = 38
VWD - Von Willebrand's DiseaseEqwilate
brief summary
MOdalities of use, effectiveNEss and TOlerability of Eqwilate® a balanced combInatiON of VWF and FVIII in von WillEbrand patients in real-life conditions: the ONE-TO-ONE study
started
Nov 27, 2019
primary completion
May 11, 2024
completion
Nov 1, 2026
last updated
Apr 18, 2025
official title
MOdalities of Use, effectiveNEss and TOlerability of Eqwilate® a Balanced combInatiON of VWF and FVIII in Von WillEbrand Patients in Real-life Conditions: the ONE-TO-ONE Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol